Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.
NCT00139087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2005-08-31
Summary
The Telephone Outreach for Therapy Trial was designed to test an intervention to assist new mothers or caregivers of HIV-exposed children with administering medication for the first 6 weeks of life to prevent mother-to-child HIV infection in the infants. To be eligible, mothers of infants were identified as HIV-infected in the Mother-Infant Rapid Intervention at Delivery Study. Mothers or caregivers of infants were randomized into two groups: the intervention group received a cellular phone and scheduled twice daily calls to assure infant medications were given, and the other group received the current standard of care. Enrollment into the study was completed and analysis of the study data is underway.
Conditions
Interventions
- BEHAVIORAL
-
Telephone Outreach for Therapy
Sponsors & Collaborators
Principal Investigators
-
Susan P Danner, BA · Centers for Disease Control and Prevention
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Hour
- Max Age
- 2 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-01-31
- Completion
- 2005-03-31
More Related Trials
-
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
NCT00076791 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
NCT00099359 ·Status: COMPLETED ·Phase: PHASE3
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
NCT01433185 ·Status: COMPLETED ·Phase: NA
-
Tenofovir Gel in Pregnancy and Lactation
NCT01136759 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.
NCT00000855 ·Status: COMPLETED ·Phase: NA
-
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
NCT00102960 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
NCT00000960 ·Status: COMPLETED ·Phase: PHASE3
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
NCT00307151 ·Status: COMPLETED ·Phase: PHASE2
-
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
NCT00270296 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
NCT00001007 ·Status: COMPLETED ·Phase: PHASE1
-
PrEP in Breastfeeding Study
NCT02776748 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiretroviral Regime for Viral Eradication in Newborns
NCT02712801 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
NCT00086359 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
NCT00001106 ·Status: COMPLETED ·Phase: PHASE1
-
Mother Infant Retention for Health: MIR4Health
NCT01962220 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women
NCT02181933 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
Primary HIV Prevention in Pregnant and Lactating Ugandan Women
NCT01882998 ·Status: COMPLETED ·Phase: NA
-
Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi
NCT06506188 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
NCT01618305 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
NCT00120471 ·Status: COMPLETED ·Phase: PHASE1
-
Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
NCT00639938 ·Status: COMPLETED ·Phase: PHASE3